Hanesbrands (HBI) Holder Cypress Capital Management Cut Its Position as Shares Declined; Hengehold Capital Management Holds Stake in Johnson & Johnson (JNJ)

Hanesbrands Inc. (NYSE:HBI) Logo

Cypress Capital Management Llc decreased its stake in Hanesbrands Inc (HBI) by 17.66% based on its latest 2018Q3 regulatory filing with the SEC. Cypress Capital Management Llc sold 58,550 shares as the company’s stock declined 15.87% with the market. The institutional investor held 272,925 shares of the clothing and shoe and accessory stores company at the end of 2018Q3, valued at $5.03M, down from 331,475 at the end of the previous reported quarter. Cypress Capital Management Llc who had been investing in Hanesbrands Inc for a number of months, seems to be less bullish one the $6.78 billion market cap company. The stock increased 1.02% or $0.19 during the last trading session, reaching $18.79. About 3.02 million shares traded. Hanesbrands Inc. (NYSE:HBI) has declined 27.36% since February 13, 2018 and is downtrending. It has underperformed by 27.36% the S&P500.

Hengehold Capital Management Llc increased its stake in Johnson & Johnson (JNJ) by 17.44% based on its latest 2018Q3 regulatory filing with the SEC. Hengehold Capital Management Llc bought 3,056 shares as the company’s stock rose 5.87% while stock markets declined. The institutional investor held 20,574 shares of the major pharmaceuticals company at the end of 2018Q3, valued at $2.84 million, up from 17,518 at the end of the previous reported quarter. Hengehold Capital Management Llc who had been investing in Johnson & Johnson for a number of months, seems to be bullish on the $359.76 billion market cap company. The stock decreased 0.01% or $0.02 during the last trading session, reaching $134.14. About 3.99M shares traded. Johnson & Johnson (NYSE:JNJ) has risen 3.75% since February 13, 2018 and is uptrending. It has outperformed by 3.75% the S&P500.

Since November 2, 2018, it had 4 buys, and 4 sales for $231,549 activity. $330,322 worth of Hanesbrands Inc. (NYSE:HBI) shares were sold by JOHNSON JOIA M. Shares for $398,750 were bought by NELSON RONALD L. $34,982 worth of Hanesbrands Inc. (NYSE:HBI) shares were sold by Mathews Jessica Tuchman. Another trade for 6,500 shares valued at $97,370 was bought by Evans Gerald. $147,340 worth of stock was bought by Hytinen Barry on Tuesday, November 20.

Analysts await Hanesbrands Inc. (NYSE:HBI) to report earnings on February, 14. They expect $0.47 earnings per share, down 9.62% or $0.05 from last year’s $0.52 per share. HBI’s profit will be $169.54 million for 9.99 P/E if the $0.47 EPS becomes a reality. After $0.55 actual earnings per share reported by Hanesbrands Inc. for the previous quarter, Wall Street now forecasts -14.55% negative EPS growth.

Investors sentiment increased to 0.86 in 2018 Q3. Its up 0.06, from 0.8 in 2018Q2. It increased, as 60 investors sold HBI shares while 180 reduced holdings. 60 funds opened positions while 146 raised stakes. 351.16 million shares or 1.42% less from 356.23 million shares in 2018Q2 were reported. Keybank National Association Oh stated it has 16,475 shares or 0% of all its holdings. 538 were reported by Gradient Investments Lc. 29,954 were accumulated by Hilltop Hldg. Principal Financial Gru Inc invested in 0.01% or 572,961 shares. State Board Of Administration Of Florida Retirement Systems holds 0.03% of its portfolio in Hanesbrands Inc. (NYSE:HBI) for 550,544 shares. 51,550 are owned by Jensen Invest Mngmt. Amp Capital invested in 111,635 shares or 0.01% of the stock. Optimum Investment stated it has 0.01% in Hanesbrands Inc. (NYSE:HBI). Howe & Rusling reported 3.08% in Hanesbrands Inc. (NYSE:HBI). Chieftain Cap accumulated 12.36 million shares. Gateway Investment Advisers Ltd Company holds 20,529 shares. Jane Street Grp Ltd Liability Com invested in 0% or 29,485 shares. Reliance Trust Company Of Delaware holds 0.04% or 14,098 shares. Cibc Asset Mngmt, a Ontario – Canada-based fund reported 36,392 shares. Prudential Fin Inc has 862,354 shares for 0.02% of their portfolio.

Among 22 analysts covering Hanesbrands (NYSE:HBI), 9 have Buy rating, 0 Sell and 13 Hold. Therefore 41% are positive. Hanesbrands had 78 analyst reports since September 17, 2015 according to SRatingsIntel. As per Friday, February 9, the company rating was maintained by B. Riley & Co. Barclays Capital maintained Hanesbrands Inc. (NYSE:HBI) on Thursday, November 2 with “Overweight” rating. On Wednesday, October 25 the stock rating was downgraded by Wells Fargo to “Market Perform”. The stock of Hanesbrands Inc. (NYSE:HBI) earned “Market Perform” rating by Cowen & Co on Wednesday, October 12. The rating was maintained by Morgan Stanley on Monday, August 7 with “Equal-Weight”. The rating was maintained by Barclays Capital on Wednesday, May 2 with “Overweight”. As per Friday, February 3, the company rating was maintained by Stifel Nicolaus. The rating was maintained by FBR Capital with “Outperform” on Friday, February 3. Barclays Capital maintained the stock with “Equal-Weight” rating in Friday, November 2 report. The firm has “Buy” rating given on Monday, December 12 by CL King.

More important recent Hanesbrands Inc. (NYSE:HBI) news were published by: Seekingalpha.com which released: “Hanesbrands +3% after strong quarter – Seeking Alpha” on February 07, 2019, also Seekingalpha.com published article titled: “Hanesbrands: Turnaround Intact, 4.3% Yield Is Attractive – Seeking Alpha”, Seekingalpha.com published: “CMG, HBI, SGMO and PRLB among notable midday movers – Seeking Alpha” on February 07, 2019. More interesting news about Hanesbrands Inc. (NYSE:HBI) was released by: Fool.com and their article: “Why Hanesbrands, iRobot, and HealthEquity Jumped Today – Motley Fool” with publication date: February 07, 2019.

Hengehold Capital Management Llc, which manages about $470.50M and $397.67M US Long portfolio, decreased its stake in Dbx Etf Tr (DBJP) by 231,596 shares to 9,599 shares, valued at $428,000 in 2018Q3, according to the filing. It also reduced its holding in Invesco Exchng Traded Fd Tr by 15,904 shares in the quarter, leaving it with 56,547 shares, and cut its stake in Procter And Gamble Co (NYSE:PG).

Investors sentiment increased to 1.05 in Q3 2018. Its up 0.08, from 0.97 in 2018Q2. It improved, as 43 investors sold JNJ shares while 748 reduced holdings. 115 funds opened positions while 719 raised stakes. 1.70 billion shares or 7.91% less from 1.84 billion shares in 2018Q2 were reported. Eagle Limited Liability Company has invested 0.32% in Johnson & Johnson (NYSE:JNJ). Panagora Asset Mngmt reported 1.19M shares stake. Adage Cap Grp Incorporated Ltd Co stated it has 3.27M shares or 1.01% of all its holdings. 159,078 are held by Meag Munich Ergo Kapitalanlagegesellschaft Mbh. Moreover, First Dallas Inc has 2.38% invested in Johnson & Johnson (NYSE:JNJ) for 27,607 shares. New York-based Loeb Prtnrs Corp has invested 1.55% in Johnson & Johnson (NYSE:JNJ). Baxter Bros Incorporated, a Connecticut-based fund reported 39,110 shares. 38,980 are owned by Woodmont Inv Counsel Lc. 17,552 are held by Longer Invs. Weybosset Research & Mgmt Limited Liability Co invested 4.79% of its portfolio in Johnson & Johnson (NYSE:JNJ). Prudential Fincl Incorporated has invested 1.08% in Johnson & Johnson (NYSE:JNJ). Amica Retiree Med Tru reported 15,246 shares. Old Point Svcs N A owns 60,275 shares for 4.36% of their portfolio. Fulton Breakefield Broenniman Ltd stated it has 113,104 shares or 2.43% of all its holdings. Fincl Advisory Group Inc stated it has 0.22% of its portfolio in Johnson & Johnson (NYSE:JNJ).

Among 25 analysts covering Johnson & Johnson (NYSE:JNJ), 12 have Buy rating, 4 Sell and 9 Hold. Therefore 48% are positive. Johnson & Johnson had 111 analyst reports since August 7, 2015 according to SRatingsIntel. The rating was maintained by Argus Research with “Buy” on Wednesday, October 18. Stifel Nicolaus maintained the stock with “Hold” rating in Wednesday, January 24 report. The firm earned “Buy” rating on Wednesday, April 18 by Wells Fargo. Cowen & Co maintained the shares of JNJ in report on Tuesday, June 13 with “Buy” rating. Jefferies upgraded Johnson & Johnson (NYSE:JNJ) on Wednesday, October 11 to “Buy” rating. The rating was upgraded by Goldman Sachs to “Neutral” on Monday, March 14. Credit Suisse maintained Johnson & Johnson (NYSE:JNJ) rating on Tuesday, June 12. Credit Suisse has “Buy” rating and $15100 target. The firm earned “Market Perform” rating on Thursday, January 26 by Wells Fargo. As per Tuesday, February 6, the company rating was maintained by Wells Fargo. The stock of Johnson & Johnson (NYSE:JNJ) earned “Sell” rating by BTIG Research on Wednesday, August 2.

More notable recent Johnson & Johnson (NYSE:JNJ) news were published by: Seekingalpha.com which released: “FDA OKs split-dosing regimen for J&J’s Darzalex – Seeking Alpha” on February 12, 2019, also Seekingalpha.com with their article: “Covered-Call Writing With J&J – Seeking Alpha” published on January 24, 2019, Seekingalpha.com published: “J&J to begin giving drug pricing in TV ads – Seeking Alpha” on February 07, 2019. More interesting news about Johnson & Johnson (NYSE:JNJ) were released by: Benzinga.com and their article: “Johnson & Johnson Wins FDA Panel Backing For Nasal Spray Depression Drug; PDUFA Date Awaits (NYSE:JNJ) – Benzinga” published on February 13, 2019 as well as Seekingalpha.com‘s news article titled: “Johnson & Johnson: P/E Matters – Seeking Alpha” with publication date: January 17, 2019.

Hanesbrands Inc. (NYSE:HBI) Institutional Positions Chart